EU Validates Two Daiichi Sankyo Lipid-Lowering Therapy Applications
The European Medicines Agency validated two marketing authorization applications from Daiichi Sankyo for single-pill triple-combination lipid-lowering therapy.
Related stories
Geely Auto Quarterly Earnings Rise 28% Amid Overhaul
Geely Auto reported a 28% jump in quarterly earnings. The commentary says the market continues to treat the Chinese automaker poorly despite changes to electrification, succession
M impact | EQUITY | Oct 30, 2026, 02:27 AM UTC
Aluminum Corp of China H Shares Rise 2.7% as Q3 Net Profit Climbs
Aluminum Corp of China’s H shares rose 2.7%; its A shares gained as much as 1.8% Friday morning. Third-quarter net profit increased year over year.
M impact | EQUITY | Oct 30, 2026, 02:26 AM UTC
Junshi Biosciences Q3 Revenue Rises 39.2%
Junshi Biosciences reported a 39.2% increase in revenue in its third-quarter report.
M impact | EQUITY | Oct 30, 2026, 02:25 AM UTC
Jakarta Stocks Fall 1.7%
M impact | EQUITY | Oct 30, 2026, 02:21 AM UTC
Indian Shares Seen Opening Higher After Earnings-Led Rebound
Indian shares are seen opening higher after an earnings-led rebound, with higher oil expected to cap gains.
M impact | EQUITY | Oct 30, 2026, 02:20 AM UTC
KHNP Seeks New Contractor for Czech Nuclear Project
KHNP is seeking a new contractor for its Czech nuclear project after talks collapsed.
M impact | EQUITY | Oct 30, 2026, 02:19 AM UTC